Matches in SemOpenAlex for { <https://semopenalex.org/work/W47567078> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W47567078 endingPage "91" @default.
- W47567078 startingPage "77" @default.
- W47567078 abstract "Previous work from this laboratory has suggested that the plasma amino acid pattern, known to be deranged in hepatic encephalopathy, may be related causally. In order to test this hypothesis, 23% dextrose and a special amino acid solution whose components were calculated to normalize the plasma amino acid pattern were infused in 11 patients, eight with chronic cirrhosis and acute exacerbation (Group 1) and three patients with fulminant hepatitis (Group 2), in amounts of up to 120 Gm. of protein equivalent per 24 hours. Plasma amino acids were abnormal but different in both groups. In Group 1 (cirrhosis) changes in plasma amino acid pattern including elevated phenylalanine, tyrosine, glutamate, aspartate, and methionine and decreased valine, leucine, and isoleucine. In Group 2 all amino acids were elevated, with the exception of the branched chains which were normal. Hepatic encephalopathy improved in all patients in Group 1 and in one of three patients in Group 2 following the infusion. The ratio (see article) showed an excellent correlation with a grade of encephalopathy. When this ratio, previously 1.0 in the presence of encephalopathy, returned to the normal value near 3.0 to 3.5, encephalopathy improved. An excellent correlation was obtained between the ratio and the grade of encephalopathy and was dose related as well. The results suggest that different amino acid patterns in hepatic encephalopathy of differing etiologies require treatment modalities which may differ for the two types of encephalopathy. Whereas amino acid infusion appears to be a valuable, efficacious way of providing nutrition in treating hepatic encephalopathy in patients with cirrhosis and acute deterioration and coma, other means of therapy such as plasms laundering appear to be necessary in patients with fulminant hepatitis." @default.
- W47567078 created "2016-06-24" @default.
- W47567078 creator A5001420424 @default.
- W47567078 creator A5003782178 @default.
- W47567078 creator A5050170832 @default.
- W47567078 creator A5051938931 @default.
- W47567078 creator A5068028007 @default.
- W47567078 creator A5085972527 @default.
- W47567078 date "1976-07-01" @default.
- W47567078 modified "2023-09-27" @default.
- W47567078 title "The effect of normalization of plasma amino acids on hepatic encephalopathy in man." @default.
- W47567078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/818729" @default.
- W47567078 hasPublicationYear "1976" @default.
- W47567078 type Work @default.
- W47567078 sameAs 47567078 @default.
- W47567078 citedByCount "208" @default.
- W47567078 countsByYear W475670782012 @default.
- W47567078 countsByYear W475670782013 @default.
- W47567078 countsByYear W475670782014 @default.
- W47567078 countsByYear W475670782015 @default.
- W47567078 countsByYear W475670782016 @default.
- W47567078 countsByYear W475670782017 @default.
- W47567078 countsByYear W475670782018 @default.
- W47567078 countsByYear W475670782021 @default.
- W47567078 countsByYear W475670782022 @default.
- W47567078 countsByYear W475670782023 @default.
- W47567078 crossrefType "journal-article" @default.
- W47567078 hasAuthorship W47567078A5001420424 @default.
- W47567078 hasAuthorship W47567078A5003782178 @default.
- W47567078 hasAuthorship W47567078A5050170832 @default.
- W47567078 hasAuthorship W47567078A5051938931 @default.
- W47567078 hasAuthorship W47567078A5068028007 @default.
- W47567078 hasAuthorship W47567078A5085972527 @default.
- W47567078 hasConcept C126322002 @default.
- W47567078 hasConcept C134018914 @default.
- W47567078 hasConcept C185592680 @default.
- W47567078 hasConcept C2776580952 @default.
- W47567078 hasConcept C2777214474 @default.
- W47567078 hasConcept C2777431362 @default.
- W47567078 hasConcept C2777573094 @default.
- W47567078 hasConcept C2777992278 @default.
- W47567078 hasConcept C2778621155 @default.
- W47567078 hasConcept C2780325230 @default.
- W47567078 hasConcept C2780912031 @default.
- W47567078 hasConcept C515207424 @default.
- W47567078 hasConcept C55493867 @default.
- W47567078 hasConcept C71924100 @default.
- W47567078 hasConcept C90924648 @default.
- W47567078 hasConceptScore W47567078C126322002 @default.
- W47567078 hasConceptScore W47567078C134018914 @default.
- W47567078 hasConceptScore W47567078C185592680 @default.
- W47567078 hasConceptScore W47567078C2776580952 @default.
- W47567078 hasConceptScore W47567078C2777214474 @default.
- W47567078 hasConceptScore W47567078C2777431362 @default.
- W47567078 hasConceptScore W47567078C2777573094 @default.
- W47567078 hasConceptScore W47567078C2777992278 @default.
- W47567078 hasConceptScore W47567078C2778621155 @default.
- W47567078 hasConceptScore W47567078C2780325230 @default.
- W47567078 hasConceptScore W47567078C2780912031 @default.
- W47567078 hasConceptScore W47567078C515207424 @default.
- W47567078 hasConceptScore W47567078C55493867 @default.
- W47567078 hasConceptScore W47567078C71924100 @default.
- W47567078 hasConceptScore W47567078C90924648 @default.
- W47567078 hasIssue "1" @default.
- W47567078 hasLocation W475670781 @default.
- W47567078 hasOpenAccess W47567078 @default.
- W47567078 hasPrimaryLocation W475670781 @default.
- W47567078 hasRelatedWork W1571954921 @default.
- W47567078 hasRelatedWork W165120425 @default.
- W47567078 hasRelatedWork W175172959 @default.
- W47567078 hasRelatedWork W1894720657 @default.
- W47567078 hasRelatedWork W1973277427 @default.
- W47567078 hasRelatedWork W1991964612 @default.
- W47567078 hasRelatedWork W2062633588 @default.
- W47567078 hasRelatedWork W2412217350 @default.
- W47567078 hasRelatedWork W2412306063 @default.
- W47567078 hasRelatedWork W47567078 @default.
- W47567078 hasVolume "80" @default.
- W47567078 isParatext "false" @default.
- W47567078 isRetracted "false" @default.
- W47567078 magId "47567078" @default.
- W47567078 workType "article" @default.